Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, February 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 98 articles: HTML format

Single Articles

1. YOSHIDA N, Yasuda T, Inagaki Y, Hasegawa D, et al
   The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis.
   J Anus Rectum Colon. 2025;9:105-116.
   PubMed    
   Abstract available
   
   

2. RODINO-JANEIRO BK, Khannous-Lleiffe O, Pigrau M, Willis JR, et al
   Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition.
   Front Microbiol. 2025;15:1441126.
   PubMed    
   Abstract available
   
   

3. PLOCIENNIK-KORYCKA PK, Pani SM, Bruc B, Contu P, et al
   Exploring Manual Therapy in the Management of Irritable Bowel Syndrome in Adults: A Scoping Review.
   Complement Ther Med. 2025 Jan 27:103136. doi: 10.1016/j.ctim.2025.103136.
   PubMed    
   Abstract available
   
   

4. FLANAGAN K, Gassner K, Lang M, Ozelyte J, et al
   Human-derived microRNA 21 regulates indole and L-tryptophan biosynthesis transcripts in the gut commensal Bacteroides thetaiotaomicron.
   mBio. 2025 Jan 29:e0392824. doi: 10.1128/mbio.03928.
   PubMed    
   Abstract available
   
   

5. ASAL MGR, El-Sayed AAI, Alsenany SA, Ramzy ZH, et al
   Self-administered active versus sham acupressure for diarrhea predominant irritable bowel syndrome: a nurse-led randomized clinical trial.
   BMC Nurs. 2025;24:106.
   PubMed    
   Abstract available
   
   

6. TRIEU TH, Vieujean S, Delhougne N, Seidel L, et al
   Confocal Endomicroscopy Intestinal Epithelial Barrier Abnormalities in Individuals Without Documented Gastro-Intestinal Disease.
   United European Gastroenterol J. 2025 Jan 28. doi: 10.1002/ueg2.12756.
   PubMed    
   Abstract available
   
   

7. GANZEVOORT IN, van der Veen AL, Alma MA, Berger MY, et al
   Children's and Their Parents' Experiences With Home-Based Guided Hypnotherapy: Qualitative Study.
   JMIR Pediatr Parent. 2025;8:e58301.
   PubMed    
   Abstract available
   
   

8. JING C, Liu T, Li Q, Zhang C, et al
   Study of dynamic brain function in irritable bowel syndrome via Hidden Markov Modeling.
   Front Neurosci. 2025;18:1515540.
   PubMed    
   Abstract available
   
   

9. FANG X, Wang X, Zheng W, Yin Y, et al
   Effect of Acupuncture on Anxiety, Depression, and Quality of Life in Patients with Irritable Bowel Syndrome: A Meta-Analysis.
   Int J Behav Med. 2025 Jan 27. doi: 10.1007/s12529-025-10348.
   PubMed    
   Abstract available
   
   

10. DOENYAS C, Clarke G, Cserjesi R
    Gut-brain axis and neuropsychiatric health: recent advances.
    Sci Rep. 2025;15:3415.
    PubMed    
    Abstract available
    
    

11. LIANG SB, Cheng HJ, Zhang QY, Han M, et al
    Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial.
    BMJ Open. 2025;15:e088410.
    PubMed    
    Abstract available
    
    

12. LAKEMEYER M, Latorre R, Blazkova K, Jensen D, et al
    Identification of a secreted protease from Bacteroides fragilis that induces intestinal pain and inflammation by cleavage of PAR2.
    bioRxiv [Preprint]. 2025 Jan 15:2025.01.15.633241.
    PubMed    
    Abstract available
    
    

13. VELDMAN F, Hawinkels K, Keszthelyi D
    Efficacy of vagus nerve stimulation in gastrointestinal disorders: a systematic review.
    Gastroenterol Rep (Oxf). 2025;13:goaf009.
    PubMed    
    Abstract available
    
    

14. CATASSI G, Catassi C
    An overview of progress in establishing a diagnostic tool for non-celiac gluten sensitivity.
    Expert Rev Mol Diagn. 2025 Jan 29:1-8. doi: 10.1080/14737159.2025.2458469.
    PubMed    
    Abstract available
    
    

15. LEI Y, Sun X, Ruan T, Lu W, et al
    Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.
    Nutr Rev. 2025 Jan 25:nuae217. doi: 10.1093.
    PubMed    
    Abstract available
    
    

16. RICCI C, Saracino IM, Valerii MC, Spigarelli R, et al
    Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A "Real-World" Open-Label Study on 1585 Patients.
    Nutrients. 2025;17:328.
    PubMed    
    Abstract available
    
    

17. XU Y, Cai Q, Zhao C, Zhang W, et al
    Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation.
    Pharmaceuticals (Basel). 2024;18:12.
    PubMed    
    Abstract available
    
    

18. ONISOR D, Avram C, Ruta F, Brusnic O, et al
    Burden of Common Mental Disorders in Ulcerative Colitis and Irritable Bowel Syndrome Patients: An Analysis of Risk Factors.
    J Clin Med. 2025;14:499.
    PubMed    
    Abstract available
    
    

19. ALMONAJJED MB, Wardeh M, Atlagh A, Ismaiel A, et al
    Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review.
    Medicina (Kaunas). 2025;61:109.
    PubMed    
    Abstract available
    
    

20. KASTI A, Katsas K, Nikolaki MD, Triantafyllou K, et al
    The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review.
    Microorganisms. 2025;13:171.
    PubMed    
    Abstract available
    
    

21. NISTICO V, Conte F, Rossetti I, Ilia N, et al
    Exploring specific alterations at the explicit and perceptual levels in sense of ownership, agency, and body schema in Functional Motor Disorder: A pilot comparative study with Irritable Bowel Syndrome.
    Cortex. 2025;184:106-119.
    PubMed    
    Abstract available
    
    

22. QI S, Zhao M, Sun Y, Boro S, et al
    Impact of vitamin D supplementation on symptom severity and quality of life in patients with irritable bowel syndrome: A meta-analysis.
    Adv Clin Exp Med. 2025 Jan 24. doi: 10.17219/acem/191463.
    PubMed    
    Abstract available
    
    

23. DARWISH B, Aboualchamat G, Al Nahhas S
    Blastocystis ST1: Protein Profile and Specific Serum Immunoglobulin in Irritable Bowel Syndrome (IBS) Patients.
    Acta Parasitol. 2025;70:27.
    PubMed    
    Abstract available
    
    

24. SINGH P, Chey SW, Nee J, Eswaran S, et al
    Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized Controlled Trial.
    Clin Gastroenterol Hepatol. 2025;23:362-364.
    PubMed    
    Abstract available
    
    

25. XIAO Y, Meng X, Luo Q, Hou X, et al
    Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study.
    Therap Adv Gastroenterol. 2025;18:17562848251314819.
    PubMed    
    Abstract available
    
    

26. KHAN Z, Muhammad SA, Amin MS, Gul A, et al
    The Efficacy of the Low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Cureus. 2025;17:e77053.
    PubMed    
    Abstract available
    
    

27. 
    Comparison chart: Some drugs for irritable bowel syndrome with diarrhea (IBS-D).
    Med Lett Drugs Ther. 2025;67:e1-e3.
    PubMed    
    
    
    

28. 
    Comparison chart: Some drugs for irritable bowel syndrome with constipation (IBS-C).
    Med Lett Drugs Ther. 2025;67:e1-e3.
    PubMed    
    
    
    

29. 
    Comparison chart: Some drugs for abdominal pain in irritable bowel syndrome (IBS).
    Med Lett Drugs Ther. 2025;67:e1-e2.
    PubMed    
    
    
    

30. 
    Comparison chart: Safety of drugs for IBS in pregnancy and lactation.
    Med Lett Drugs Ther. 2025;67:e1-e2.
    PubMed    
    
    
    

31. 
    Drugs for irritable bowel syndrome.
    Med Lett Drugs Ther. 2025;67:17-24.
    PubMed    
    
    
    

32. PEREYRA F, Schlottmann F, Casas MA, Steinberg L, et al
    Exploring the gut-brain axis in a large cohort of patients with irritable bowel syndrome: Is there a link between depression and intestinal and extra-intestinal symptoms?
    Gastroenterol Hepatol. 2025 Feb 3:502370. doi: 10.1016/j.gastrohep.2025.502370.
    PubMed    
    Abstract available
    
    

33. PURI S, Nath DK, Lee Y
    Regulation of Feeding and Defecation in Drosophila by Trpgamma, Piezo, and DH44R2.
    Insect Biochem Mol Biol. 2025 Feb 3:104267. doi: 10.1016/j.ibmb.2025.104267.
    PubMed    
    Abstract available
    
    

34. SUN Q, Weng RX, Li YC, Jia SM, et al
    Potentiation of visualized exosomal miR-1306-3p from primary sensory neurons contributes to chronic visceral pain via spinal P2X3 receptors.
    Pain. 2025 Feb 3. doi: 10.1097/j.pain.0000000000003537.
    PubMed    
    Abstract available
    
    

35. DOGHISH AS, Elazazy O, Mohamed HH, Mansour RM, et al
    A Review on miRNAs in Enteric Bacteria-mediated Host Pathophysiology: Mechanisms and Implications.
    J Biochem Mol Toxicol. 2025;39:e70160.
    PubMed    
    Abstract available
    
    

36. URIOT O, Deschamps C, Scanzi J, Brun M, et al
    Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL).
    Bioengineered. 2025;16:2458362.
    PubMed    
    Abstract available
    
    

37. SMIRNOFF L, Moskatel LS
    Dyspareunia and pelvic pain in women with chronic migraine: A retrospective, observational analysis.
    Headache. 2025 Feb 4. doi: 10.1111/head.14905.
    PubMed    
    Abstract available
    
    

38. CHEN X, Tang R, Jin Y, Wu L, et al
    Similarities and Differences in Resting-State Brain Activity Changes of Distinct Chronic Pain Types.
    Oral Dis. 2025 Feb 4. doi: 10.1111/odi.15271.
    PubMed    
    Abstract available
    
    

39. HAMAL A, Shin A, van Tilburg MAL
    Yoga, Meditation, Mindfulness, or Hypnotherapy for GI Disorders: Similar Mechanisms of Action?
    Neurogastroenterol Motil. 2025 Feb 3:e15014. doi: 10.1111/nmo.15014.
    PubMed    
    Abstract available
    
    

40. BERENTSEN B, Thuen C, Hillestad EMR, Steinsvik EK, et al
    The Effects of Digital eHealth Versus Onsite 2-Day Group-Based Education in 255 Patients With Irritable Bowel Syndrome: Cohort Study.
    JMIR Hum Factors. 2025;12:e43618.
    PubMed    
    Abstract available
    
    

41. TUNCEL ET, Ozcan SS, Korkmaz M, Borekci E, et al
    Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome.
    PeerJ. 2025;13:e18859.
    PubMed    
    Abstract available
    
    

42. 
    Reasons for Treatment Discontinuation in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.
    Gastroenterol Hepatol (N Y). 2024;20.
    PubMed    
    
    
    

43. 
    Impact of Weight on the Efficacy, Time to Response, and Safety of Linaclotide in Adults With Chronic Idiopathic Constipation or Irritable Bowel Syndrome With Constipation: Post Hoc Descriptive Analysis by Body Mass Index.
    Gastroenterol Hepatol (N Y). 2024;20.
    PubMed    
    
    
    

44. 
    Efficacy and Safety of Plecanatide in Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation.
    Gastroenterol Hepatol (N Y). 2024;20.
    PubMed    
    
    
    

45. 
    Patients With Irritable Bowel Syndrome With Constipation From the IBS in America 2024 Real-World Survey Experience Burdensome Symptoms Beyond Constipation.
    Gastroenterol Hepatol (N Y). 2024;20.
    PubMed    
    
    
    

46. 
    Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation and Bloating: Evaluation Using Trisymptom Composite Endpoints.
    Gastroenterol Hepatol (N Y). 2024;20.
    PubMed    
    
    
    

47. 
    Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.
    Gastroenterol Hepatol (N Y). 2024;20.
    PubMed    
    
    
    

48. LI Y, Mai Y, Jiao Y, Yuan Y, et al
    Alterations in the Tongue Coating Microbiome in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Cross-Sectional Study.
    APMIS. 2025;133:e70001.
    PubMed    
    Abstract available
    
    

49. KHALIL J, Hill H, Einstadter D, Fass R, et al
    Combined oral contraceptives are associated with increased risk of developing gastroparesis in pre-menopausal women.
    Dig Liver Dis. 2025 Feb 1:S1590-8658(25)00202-6. doi: 10.1016/j.dld.2025.
    PubMed    
    Abstract available
    
    

50. PROSPERO L, Riezzo G, D'Attoma B, Ignazzi A, et al
    The impact of locus of control on somatic and psychological profiles of patients with irritable bowel syndrome engaging in aerobic exercise.
    Sci Rep. 2025;15:3966.
    PubMed    
    Abstract available
    
    

51. DENT E, Davinson N, Wilkie S, Stevens D, et al
    A qualitative exploration into the lived experiences of females with a gastrointestinal condition.
    J Health Psychol. 2025 Jan 31:13591053251315685. doi: 10.1177/13591053251315685.
    PubMed    
    Abstract available
    
    

52. POGREBA BROWN K, Austhof E, McFadden CM, Scranton C, et al
    Determining the incidence, risk factors and biological drivers of irritable bowel syndrome (IBS) as part of the constellation of postacute sequelae of SARS-CoV-2 infection (PASC) outcomes in the Arizona CoVHORT-GI: a longitudinal cohort study.
    BMJ Open. 2025;15:e095093.
    PubMed    
    Abstract available
    
    

53. TSAI K, Xu P, Guo J, Dean N, et al
    Do Bowel Disorders Affect Holmium Laser Enucleation of Prostate Outcomes? A Retrospective Cohort Study.
    Ther Adv Urol. 2025;17:17562872251317918.
    PubMed    
    Abstract available
    
    

54. MINJOZ S, Jeanne R, Vercueil L, Sabourdy C, et al
    Heart Rate Variability Biofeedback to Manage the Mental Health of Adults With Irritable Bowel Syndrome: A Pilot Study.
    Stress Health. 2025;41:e70015.
    PubMed    
    Abstract available
    
    

55. LIU D, Cao M, Wu S, Jiang Y, et al
    Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach.
    eGastroenterology. 2025;3:e100126.
    PubMed    
    Abstract available
    
    

56. LUCARINI E, Aguilera-Lizarraga J, Tejada MA
    Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions.
    Front Pharmacol. 2025;16:1546059.
    PubMed    
    
    
    

57. HAO Y, Qi J, Huang X, Liu C, et al
    Euodiae Fructus: a review of botany, application, processing, phytochemistry, quality control, pharmacology, and toxicology.
    Front Pharmacol. 2025;16:1509032.
    PubMed    
    Abstract available
    
    

58. HACKER KS, Bedell A
    Reproductive and sexual health concerns in gastrointestinal illness: a narrative review.
    Transl Gastroenterol Hepatol. 2024;10:15.
    PubMed    
    Abstract available
    
    

59. KRYNICKA P, Koulaouzidis G, Skonieczna-Zydecka K, Marlicz W, et al
    Application of Raman Spectroscopy in Non-Invasive Analysis of the Gut Microbiota and Its Impact on Gastrointestinal Health.
    Diagnostics (Basel). 2025;15:292.
    PubMed    
    Abstract available
    
    

60. YOUSSOUFI N, Jaafari A, Mansour S, El Hamdi M, et al
    A Two-for-One Diagnosis: A Rare Case of Chronic Abdominal Pain Caused by Gastroptosis and Wilkie's Syndrome in a Young Woman.
    Diagnostics (Basel). 2025;15:270.
    PubMed    
    Abstract available
    
    

61. ALOISIO CARUSO E, De Nunzio V, Tutino V, Notarnicola M, et al
    The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology.
    Int J Mol Sci. 2025;26:1306.
    PubMed    
    Abstract available
    
    

62. MOLINO S, De Lellis LF, Morone MV, Cordara M, et al
    Improving Irritable Bowel Syndrome (IBS) Symptoms and Quality of Life with Quebracho and Chestnut Tannin-Based Supplementation: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.
    Nutrients. 2025;17:552.
    PubMed    
    Abstract available
    
    

63. ZHANG H, Su Q
    Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome.
    Nutrients. 2025;17:544.
    PubMed    
    Abstract available
    
    

64. ANTONELLI A, Bianchi M, Fear EJ, Giorgi L, et al
    Management of Fibromyalgia: Novel Nutraceutical Therapies Beyond Traditional Pharmaceuticals.
    Nutrients. 2025;17:530.
    PubMed    
    Abstract available
    
    

65. TOVO PA, Ribaldone DG, Caviglia GP, Calvi C, et al
    Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1.
    Cells. 2025;14:196.
    PubMed    
    Abstract available
    
    

66. LIU H, Shao S, Chen B, Yang S, et al
    Mendelian randomization analysis reveals causal relationship between tonsillectomy and irritable bowel syndrome.
    Front Surg. 2025;12:1436227.
    PubMed    
    Abstract available
    
    

67. REXWINKEL R, Vermeijden NK, Zeevenhooven J, Kelder J, et al
    The low FODMAP diet in adolescents functional abdominal in a non-guided setting: a prospective multicenter cohort study.
    Eur J Pediatr. 2025;184:189.
    PubMed    
    Abstract available
    
    

68. CHEN Y, Fang JY
    The role of colonic microbiota amino acid metabolism in gut health regulation.
    Cell Insight. 2025;4:100227.
    PubMed    
    Abstract available
    
    

69. GAO Y, Chen C, Huang X, Liu Y, et al
    Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome.
    J Inflamm Res. 2025;18:1689-1701.
    PubMed    
    Abstract available
    
    

70. THOMAS NS, Gillespie NA, Neale MC, Rosmalen JGM, et al
    Clinical heterogeneity in major depressive disorder underlies comorbidity with functional disorders.
    J Psychiatr Res. 2025;183:16-24.
    PubMed    
    Abstract available
    
    

71. GROSEN AK, Boldsen JK, Mikkelsen S, Mark Dahl Baunwall S, et al
    Gastrointestinal symptoms and bowel habits in 53 046 healthy Danish blood donors: a nationwide cross-sectional study.
    BMJ Open Gastroenterol. 2025;12:e001518.
    PubMed    
    Abstract available
    
    

72. HEYMANN JB, White KS, Bruce SE
    The Relationship Between Trauma Exposure, PTSD Symptoms, and Gastrointestinal Symptoms.
    Int J Behav Med. 2025 Feb 21. doi: 10.1007/s12529-025-10355.
    PubMed    
    Abstract available
    
    

73. KORETZ RL
    JPEN Journal Club 91. Choosing the population to study.
    JPEN J Parenter Enteral Nutr. 2025 Feb 19. doi: 10.1002/jpen.2737.
    PubMed    
    
    
    

74. SILVA BCD, Ramos GP, Barros LL, Ramos AFP, et al
    DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.
    Arq Gastroenterol. 2025;62:e24107.
    PubMed    
    Abstract available
    
    

75. YU RL, Weber HC
    Irritable bowel syndrome, the gut microbiome, and diet.
    Curr Opin Endocrinol Diabetes Obes. 2025.
    PubMed    
    Abstract available
    
    

76. WANG L, Cao W, Zheng QH, Li D, et al
    Relationship Between FODMAP Diet and Irritable Bowel Syndrome: A Mendelian Randomization Study.
    Food Sci Nutr. 2025;13:e70037.
    PubMed    
    Abstract available
    
    

77. DURSA EK, Cypel YS, Culpepper WJ, Bernhard PA, et al
    The Physical and Mental Health of Post-9/11 Female and Male Veterans: Findings from the Comparative Health Assessment Interview Research Study.
    J Womens Health (Larchmt). 2025 Feb 18. doi: 10.1089/jwh.2024.0605.
    PubMed    
    Abstract available
    
    

78. ALEXANDERSSON BT, Jones MP, Forsberg A, Hedin CRH, et al
    Uncomplicated Diverticulosis Is Not Associated With Abdominal Pain or Abnormal Bowel Habit-A Population-Based Swedish Cohort Study.
    Neurogastroenterol Motil. 2025 Feb 17:e70000. doi: 10.1111/nmo.70000.
    PubMed    
    Abstract available
    
    

79. LU JN, Dou JH, Yi ZL, Lian L, et al
    EXPRESS: Upregulation of LRRC8A in the anterior cingulate cortex mediates chronic visceral pain in adult male mice with neonatal maternal deprivation.
    Mol Pain. 2025 Feb 17:17448069251324645. doi: 10.1177/17448069251324645.
    PubMed    
    Abstract available
    
    

80. PHAN TN, Tran QK, Truong XL, Nguyen THT, et al
    Anxiety and Depression Disorders in Vietnamese Patients With Irritable Bowel Syndrome: A Cross-Sectional Clinic-Based Study.
    JGH Open. 2025;9:e70116.
    PubMed    
    Abstract available
    
    

81. PALMIERI B, Vadala M
    Clinoptilolite in the drug refractory chronic diarrhoea.
    Clin Ter. 2025;176:6-12.
    PubMed    
    Abstract available
    
    

82. JIANAN Y, Kunming C, Chao LI, Xiang Z, et al
    Atractylenolide I ameliorates post-infectious irritable bowel syndrome by inhibiting the polymerase I and transcript release factor and c-Jun N-terminal kinase/inducible nitric oxide synthase pathway.
    J Tradit Chin Med. 2025;45:57-65.
    PubMed    
    Abstract available
    
    

83. SITING LI, Shaojun W, Yehui Y, Gejing DE, et al
    Electroacupuncture alleviates zymosan-induced colorectal hypersensitivity.
    J Tradit Chin Med. 2025;45:32-38.
    PubMed    
    Abstract available
    
    

84. KERN D, Ljotsson B, Lonndahl L, Hedman-Lagerlof E, et al
    Self-Guided vs Clinician-Guided Online Cognitive Behavioral Therapy for Atopic Dermatitis: A Randomized Clinical Trial.
    JAMA Dermatol. 2025;161:183-190.
    PubMed    
    Abstract available
    
    

85. SHIN A
    Editorial: Alpha(2)-Delta Ligands in Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Jan 30. doi: 10.1111/apt.18528.
    PubMed    
    
    
    

86. CAMILLERI M, Ford AC
    Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut-Brain Interaction of Lower Gastrointestinal Tract.
    Aliment Pharmacol Ther. 2025 Feb 2. doi: 10.1111/apt.18527.
    PubMed    
    Abstract available
    
    

87. HOLTMANN G, Moniruzzaman MD, Shah A
    Decoding the Gut-Brain Axis: A Journey Towards Targeted Interventions for Disorders-of-Gut-Brain Interaction.
    Dig Dis. 2025 Feb 12:1-14. doi: 10.1159/000543845.
    PubMed    
    Abstract available
    
    

88. VARMA S, Scott LL, Sibelli A, Pathipati M, et al
    Digital Gut-Directed CBT May Improve Fecal Incontinence in IBS.
    Dig Dis Sci. 2025 Feb 14. doi: 10.1007/s10620-025-08871.
    PubMed    
    Abstract available
    
    

89. SINGH P, Chey WD, Takakura W, Cash BD, et al
    A novel, IBS-specific IgG ELISA-based elimination diet in irritable bowel syndrome: A randomized, sham-controlled trial.
    Gastroenterology. 2025 Jan 31:S0016-5085(25)00328.
    PubMed    
    Abstract available
    
    

90. AGUILERA-LIZARRAGA J, Lopez-Lopez C, Jaramillo-Polanco J, Florens MV, et al
    Psychological stress-induced local immune response to food antigens increases pain signaling across the gut in mice.
    Gastroenterology. 2025 Feb 18:S0016-5085(25)00371.
    PubMed    
    Abstract available
    
    

91. TORICES L, Bonfiglio F, Esteban-Blanco C, Zamfir-Taranu A, et al
    Domain-specific effects of sucrase-isomaltase genotype in irritable bowel syndrome.
    Gastroenterology. 2025 Feb 11:S0016-5085(25)00362.
    PubMed    
    
    
    

92. WRIGHT-HUGHES A, Ow PL, Alderson SL, Ridd MJ, et al
    Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial.
    Gut. 2025 Jan 25:gutjnl-2024-334490. doi: 10.1136/gutjnl-2024-334490.
    PubMed    
    Abstract available
    
    

93. ORDAZ-ALVAREZ HR, Priego-Parra BA, Reyes-Diaz SA, Garcia-Zermeno KR, et al
    Prevalence of Eating Disorders Among Adults With Irritable Bowel Syndrome: A Cross-Sectional Study.
    J Clin Gastroenterol. 2024 Nov 12. doi: 10.1097/MCG.0000000000002101.
    PubMed    
    Abstract available
    
    

94. LOO QY, Chuah KH, Hian WX, Khoo XH, et al
    Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1111/jgh.16891.
    PubMed    
    Abstract available
    
    

95. SANDBERG-JANZON A, Karling P
    Prescription of commonly used drugs in patients with functional bowel disorders. A cross-sectional comparison with the general population.
    Scand J Gastroenterol. 2025 Jan 25:1-9. doi: 10.1080/00365521.2025.2458070.
    PubMed    
    Abstract available
    
    

96. CYMBAL M, Chatterjee A, Ajayi-Fox P, Lyu R, et al
    Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome.
    Scand J Gastroenterol. 2025 Jan 24:1-5. doi: 10.1080/00365521.2025.2456491.
    PubMed    
    Abstract available
    
    

97. TATTAN M, Rosmalen J, Hanssen D
    Factors associated with receiving a Functional Disorder diagnostic label: A systematic review.
    PLoS One. 2025;20:e0317236.
    PubMed    
    Abstract available
    
    

98. ZHOU J, Lamichhane N, Xu Z, Wang J, et al
    The effect of acupuncture on quality of life in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314678.
    PubMed    
    Abstract available